Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 9;15(1):90.
doi: 10.3390/biom15010090.

Elevated Kappa Index in the Absence of Cerebrospinal Fluid IgG Oligoclonal Bands: Contribution of Intrathecal IgM and IgA Synthesis

Affiliations

Elevated Kappa Index in the Absence of Cerebrospinal Fluid IgG Oligoclonal Bands: Contribution of Intrathecal IgM and IgA Synthesis

Krzysztof Smolik et al. Biomolecules. .

Abstract

The kappa index is a well-established marker of intrathecal synthesis (IS) of immunoglobulin (Ig). Routinely used for diagnostic aims, IgG IS, which can be assessed quantitatively (ad hoc formulas) or qualitatively (oligoclonal bands, OCBs), may fail in detecting a humoral immune response within the central nervous system (CNS). The main aim of this study was to evaluate the kappa index for its ability to detect the presence of CNS humoral immunity and to associate it with a distinct group of disorders, in the absence of IgG IS/OCBs. Within the kappa index-positive, IgG OCB-negative (Kappa+OCB-) patient group, we also examined whether IgM/IgA IS, determined with the IgM/IgA index and CSF IgM OCBs, could contribute to disease group stratification. Diagnoses were classified as multiple sclerosis (MS), or other inflammatory (INFL), infectious (INFECT), or non-inflammatory (Other) central/peripheral nervous system disorders. Sixty-nine Kappa+OCB- patients and 50 controls (24 Kappa-OCB- and 26 Kappa+OCB+ patients) were included in this study. The most frequent diagnosis in the Kappa+OCB- group was MS (27/69), followed by INFECT (16/69). Additional evidence of IS was demonstrated through an elevated IgG/IgM/IgA index or by the presence of IgM OCBs in 59%, and through only IgM/IgA IS in 52% of cases. In INFECT patients, the median IgM/IgA indexes were higher (p < 0.001) than in other groups, with 18 patients (95%) presenting an elevated IgM index, 11 patients (58%) presenting CSF IgM OCBs, and 10 patients (53%) presenting an elevated IgA index. The vast majority of all INFECT (16/19) belonged to the Kappa+OCB- group. Our data confirm that the kappa index performs at the highest level in assessing intrathecal humoral immunity and supporting the diagnosis of both MS and CNS infectious disorders, which are also characterized by the intrathecal production of IgM and IgA.

Keywords: IgM/IgA intrathecal synthesis; kappa index; oligoclonal bands.

PubMed Disclaimer

Conflict of interest statement

The study received unconditional support from Binding Site (Birmingham, UK) through the supply of the necessary Freelite kits. Diana Ferraro received travel grants and/or speaking honoraria from Binding Site. The other authors declare no conflicts of interests.

Figures

Figure 1
Figure 1
Reibergrams of Kappa+OCB- (A), Kappa-OCB- (B), and Kappa+OCB+ (C) patients. The quotients are indicated with black squares in relation to their CSF/serum albumin quotients (Qalb). IgG/M/A intrathecal synthesis can be assumed when the Q kappa is above the bold line, depicting the hyperbolic border line of Q Ig (lim). The grey percentile lines with 40%, 60%, and 80% represent the fraction of IgG/M/A that has been synthesized in the CSF in relation to the total amount of the molecule in the CSF. Contrarily, values falling into the striped area of the graph are not indicative of IgG/M/A IS. The lower line indicates the lower limit of the reference range (Q Ig low). Modified version of graphs created using the free software available at Albaum (www.albaum.it, accessed on 18 June 2024).

References

    1. Hegen H., Walde J., Berek K., Arrambide G., Gnanapavan S., Kaplan B., Khalil M., Saadeh R., Teunissen C., Tumani H., et al. Cerebrospinal Fluid Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-Analysis. Mult. Scler. J. 2023;29:169–181. doi: 10.1177/13524585221134213. - DOI - PMC - PubMed
    1. Ferraro D., Bedin R., Natali P., Franciotta D., Smolik K., Santangelo M., Immovilli P., Camera V., Vitetta F., Gastaldi M., et al. Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders. Diagnostics. 2020;10:856. doi: 10.3390/diagnostics10100856. - DOI - PMC - PubMed
    1. Hegen H., Arrambide G., Gnanapavan S., Kaplan B., Khalil M., Saadeh R., Teunissen C., Tumani H., Villar L.M., Willrich M.A.V., et al. Cerebrospinal Fluid Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis: A Consensus Statement. Mult. Scler. J. 2023;29:182–195. doi: 10.1177/13524585221134217. - DOI - PMC - PubMed
    1. Natali P., Bedin R., Bernardi G., Corsini E., Cocco E., Schirru L., Crespi I., Lamonaca M., Sala A., Nicolò C., et al. Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements. Biomolecules. 2022;12:677. doi: 10.3390/biom12050677. - DOI - PMC - PubMed
    1. Villar L., García-Barragán N., Espiño M., Roldán E., Sádaba M., Gómez-Rial J., González-Porqué P., Álvarez-Cermeño J. Influence of Oligoclonal IgM Specificity in Multiple Sclerosis Disease Course. Mult. Scler. J. 2008;14:183–187. doi: 10.1177/1352458507082046. - DOI - PubMed

LinkOut - more resources